Home > > > Report Detail

Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 16-Aug-2019
No. of pages: 97
Inquire Before Buying

Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.

In 2018, the global Latent Tuberculosis Infection (LTBI) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Qiagen

- BioMerieux

- Thermo Fisher Scientific

- Danaher

- Roche

- Becton Dickinson

- Agilent Technologies

- Bio-Rad Laboratories

- Eppendorf

- Abbott Laboratories

Market segment by Type, the product can be split into

- Tuberculin Skin Test (TST)

- Interferon Gamma Released Assay (IGRA)

- Others

Market segment by Application, split into

- Household Contacts with Pulmonary TB

- PLHIV

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.

- To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Tuberculin Skin Test (TST)
1.4.3 Interferon Gamma Released Assay (IGRA)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2025)
1.5.2 Household Contacts with Pulmonary TB
1.5.3 PLHIV
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size
2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2019-2025)
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
3 Market Share by Key Players
3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by by Players
3.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by by Players (2014-2019)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by by Players (2014-2019)
3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.2 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
3.3 Key Players Latent Tuberculosis Infection (LTBI) Testing Product/Solution/Service
3.4 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2014-2019)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2014-2019)
5 North America
5.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
5.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America
5.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
5.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
6 Europe
6.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe
6.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
7 China
7.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China
7.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
7.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
8 Japan
8.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan
8.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
8.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia
9.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
9.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
10 India
10.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India
10.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
10.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
11 Central & South America
11.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America
11.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
11.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
12 International Players Profiles
12.1 Qiagen
12.1.1 Qiagen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019))
12.1.5 Qiagen Recent Development
12.2 BioMerieux
12.2.1 BioMerieux Company Details
12.2.2 Company Description and Business Overview
12.2.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.2.4 BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.2.5 BioMerieux Recent Development
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.3.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.3.5 Thermo Fisher Scientific Recent Development
12.4 Danaher
12.4.1 Danaher Company Details
12.4.2 Company Description and Business Overview
12.4.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.4.4 Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.4.5 Danaher Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.5.4 Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Becton Dickinson
12.6.1 Becton Dickinson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.6.4 Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.6.5 Becton Dickinson Recent Development
12.7 Agilent Technologies
12.7.1 Agilent Technologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.7.4 Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.7.5 Agilent Technologies Recent Development
12.8 Bio-Rad Laboratories
12.8.1 Bio-Rad Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.8.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.8.5 Bio-Rad Laboratories Recent Development
12.9 Eppendorf
12.9.1 Eppendorf Company Details
12.9.2 Company Description and Business Overview
12.9.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.9.4 Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.9.5 Eppendorf Recent Development
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.10.4 Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.10.5 Abbott Laboratories Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Latent Tuberculosis Infection (LTBI) Testing Key Market Segments
Table Key Players Latent Tuberculosis Infection (LTBI) Testing Covered
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Tuberculin Skin Test (TST) Figures
Table Key Players of Tuberculin Skin Test (TST)
Figuer Interferon Gamma Released Assay (IGRA) Figures
Table Key Players of Interferon Gamma Released Assay (IGRA)
Figuer Others Figures
Table Key Players of Others
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2018 & 2025
Figure Household Contacts with Pulmonary TB Case Studies
Figure PLHIV Case Studies
Figure Others Case Studies
Figure Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions 2019-2025 (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions 2019-2025 (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions 2014-2019
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions 2014-2019
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Latent Tuberculosis Infection (LTBI) Testing Revenue by by Players (2014-2019) (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Share by by Players (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Share by by Players in 2018
Table Global Latent Tuberculosis Infection (LTBI) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Latent Tuberculosis Infection (LTBI) Testing Product/Solution/Service
Table Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2014-2019) (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Type (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2014-2019)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2014-2019) (Million US$)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2014-2019)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application in 2018
Figure North America Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table North America Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table North America Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table China Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table China Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Japan Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure India Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table India Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table India Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Figure Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Latent Tuberculosis Infection (LTBI) Testing Market Share (2018-2019)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type 2014-2019 (Million US$)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type 2014-2019
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application 2014-2019 (Million US$)
Table Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application 2014-2019
Table Qiagen Company Details
Table Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Qiagen Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure BioMerieux Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table BioMerieux Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Danaher Company Details
Table Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Danaher Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Danaher Recent Development
Table Roche Company Details
Table Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Roche Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Becton Dickinson Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Becton Dickinson Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Agilent Technologies Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table Eppendorf Company Details
Table Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Eppendorf Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Eppendorf Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business 2014-2019 (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Regions (2019-2025)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Regions in 2025
Figure North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Product (2019-2025)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Product in 2025
Table Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2019-2025)
Figure Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs